Advances in γδ T cell-mediated immune surveillance in cervical cancer

Advances in platinum-based drug development for cervical cancer therapy
Donghan Shao, Ping Gao, Qian Wang +5
Frontiers in Pharmacology28 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref
POST-TREATMENT SURVEILLANCE AND MANAGEMENT OF RECURRENT CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
Aurélie Buffeteau, Abel Cordoba, Jean Levêque +45
Journal of Gynecology Obstetrics and Human Reproduction3 Nov 2026Peer-reviewedCC BYFull textGeneral biology OncologyHAL
Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
Xingwei Wang, Ziyue Zhang, Mei Chen +4
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Minimal residual disease in cervical cancer: biological persistence, ctHPV DNA-guided surveillance, and recurrence-directed intervention.
Jing Wu, Teng Wang, Chunyue Sheng +1
Frontiers in oncology22 Sep 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
Radiomics modeling to predict the tumor immune-microenvironment of mucinous adenocarcinoma of gastric-type cervical cancer
Risa Matsuda, Kohei Oguma, Hiroshi Nishio +10
Scientific Reports9 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyCrossref

Cite

BibTeX

@article{wang2026advances,
  title = {{Advances in γδ T cell-mediated immune surveillance in cervical cancer}},
  author = {Jinlei Wang and Xiujun Xu and Qiang Li},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655783},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Advances in γδ T cell-mediated immune surveillance in cervical cancer
AU  - Jinlei Wang
AU  - Xiujun Xu
AU  - Qiang Li
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in oncology
UR  - https://europepmc.org/article/PMC/PMC13655783
SN  - 2234-943X
ER  -

Related

Cite